Osteoblastoma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
- March 2036
- 0 pages
Osteoblastoma is a rare, benign bone (osteoblastic) tumor that most commonly occurs at the spine, long bones, the sacrum, and flat bones. This tumor does not spread in the body. However, an aggressive type of osteoblastoma can lead to metastasis and death and even mimic osteosarcoma. Out of all primary bone tumors, osteoblastoma accounts for about 1% to 2%. This tumor differs from osteoid osteoma by its aggressive behavior in bone and its ability to grow larger than 2.0 cm in diameter. It occurs more commonly in younger men (median age of 18 years), but can affect any age group, as young as two years and as old as 70 years. Of all the diagnosed cases of osteoblastoma, 80% of the tumor occur within 10 to 30 years of age. The male to female ratio is 2:1. Common symptoms of the tumor include pain (generally increases in severity over time), swelling, and atrophy in affected areas. The osteoblastoma in the spine causes painful scoliosis, muscle spasms, and limited range of motion. It is diagnosed by physical examination followed by X-ray, magnetic resonance imaging, computerized tomography, bone scan, and blood test.
The treatment of osteoblastoma involves a surgical operation to remove the tumor as chemotherapy and radiation therapy are not effective. Based on surgery type, the osteoblastoma treatment market is segmented into en bloc resection and curettage and bone grafting.
- En bloc resection: This operation removes the portion of the bone containing the tumor.
- Curettage and bone grafting: This surgical procedure involves scraping the tumor out of the bone using a special instrument called curette; the remaining cavity is sometimes packed with bone chips from a donor bone graft or from another bone.
The rising incidence and prevalence of osteoblastoma and growing awareness among people are key drivers that contribute to the growth of the global osteoblastoma treatment market. However, high cost of treatment and side effects associated with the treatment might hamper the global market growth for osteoblastoma treatment.
Geographically, the osteoblastoma treatment market is segmented into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America dominates the global market, followed by Europe. Factors such as increase in incidence rate of osteoblastoma, rise in awareness among people, availability of well-qualified health care professionals, and established health care infrastructure contribute to the growth of the North America market. Asia Pacific is anticipated to expand at a high a CAGR during the forecast period owing to increased government initiatives and developing health care infrastructure in India and China. However, lack of proper treatment and poor patient awareness in Latin America and Middle East & Africa are factors restraining the market growth in these regions.
The leading players operating in the global osteoblastoma treatment market include Children’s Hospital of Philadelphia, Dana-Farber Cancer Institute, and Boston Children's Hospital.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017